Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug

Molecular Pharmacology

Volumn 59, Issue 6, 2001, Pages 1542-1548

  Mata, J F ^a   Garcia Manteiga J M ^a   Lostao, M P ^a   Fernandez Veledo S ^a   Guillen Gomez E ^a   Larrayoz, I M ^a   Lloberas, J ^a   Casado, F J ^a   Pastor Anglada, M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CARRIER PROTEIN; CISPLATIN; DOXIFLURIDINE; DRUG METABOLITE; FLUOROURACIL; HUMAN CONCENTRATIVE NUCLEOSIDE TRANSPORTER 1; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CELL MEMBRANE TRANSPORT; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG METABOLISM; ELECTROPHYSIOLOGY; FETUS LIVER; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; VOLTAGE CLAMP;

EID: 0034984732     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.6.1542     Document Type: Article

References (25)

1. Nucleoside transporters: Molecular biology and implications for therapeutic development
2. Potential of Xeloda in colorectal cancer and other solid tumors
3. Differential expression and regulation of nucleoside transport systems in rat liver parenchymal and hepatoma cells
4. Selective loss of nucleoside carrier expression in rat hepatocarcinomas
5. Electrophysiological analysis of the substrate selectivity of a sodium-coupled nucleoside transporter (rCNT1) expressed in Xenopus laevis oocytes
6. Increased cytotoxicity and bystander effect of 5′-fluorouracil and 5′-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase
7. +-dependent nucleoside transport in liver: Two different isoforms from the same gene family are expressed in liver cells
8. +/glucose co-transporter
9. +-glucose co-transporters
10. Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA
11. Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes
12. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines
13. Gemcitabine transport in Xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters
14. Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tissues
15. Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapies
16. Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase
17. Transient expression of a purine-selective nucleoside transporter (SPNTint) in a human cell line (Hela)
18. Regulation of nucleoside transport by lipopolysaccharide, phorbol esters, and tumor necrosis factor-alpha in human B-lymphocytes
19. Nitric oxide regulates nucleoside transport in activated B lymphocytes
20. Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: Results of a randomized phase II study
21. Rational design of new tumor-activated (TM) cytotoxic agents
22. Phase I and pharmacokinetic study of the oral fluoropyrimidine capecitabine in combination with paclixatel in patients with advanced solid malignancies
23. +-dependent nucleoside transporters
24. Transport of adenosine by recombinant purine- and pyrimidine-selective sodium/nucleoside cotransporters from rat jejunum expressed in Xenopus laevis oocytes
25. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors